AZITHROMYCIN AND CO-AMOXICLAV AT DIFFERENT DOSAGES HAVE BEEN PROMOTED FOR TREATING CHILDREN WITH LOWER RESPIRATORY TRACT INFECTIONS (Anupriya , Trans.). (2026). Cuestiones De Fisioterapia, 53(02), 5041-5046. https://doi.org/10.48047/dhpsth87